Types of NSAIDs:
- Salicylates (both acetylated, such as aspirin and nonacetylated)
- Traditional NSAIDs
- COX-2 Selective Inhibitors
NSAIDs work by blocking the activity of the enzyme, cyclooxygenase, also known as COX. Research has revealed that there are two forms, known as COX-1 and COX-2. NSAIDs affect both forms. COX-1 is involved in maintaining healthy tissue.
COX-2 is involved in the inflammation pathway. COX-2 Selective Inhibitors became a subset of NSAIDs born of this research.
Traditional NSAIDs include:
- Ansaid (Flurbiprofen)
- Arthrotec (Diclofenac/Misoprostol)
- Cataflam (Diclofenac Potassium)
- Clinoril (Sulindac)
- Daypro (Oxaprozin)
- Dolobid (Diflunisal)
- Feldene (Piroxicam)
- Ibuprofen (Motrin, Advil)
- Indocin (Indomethacin)
- Ketoprofen (Orudis)
- Lodine (Etodolac)
- Meclomen (Meclofenamate)
- Mobic (Meloxicam)
- Nalfon (Fenoprofen)
- Naproxen (Naprosyn, Aleve)
- Ponstel (Mefanamic Acid)
- Relafen (Nabumetone)
- Tolectin (Tolmetin)
- Voltaren (Dicolfenac Sodium)
COX-2 Inhibitors include:
- Celebrex (Celecoxib)
- Vioxx (Rofecoxib)(no longer on market)
- Bextra (Valdecoxib)(no longer on market)
In April 2005, The FDA announced actions regarding the marketing of NSAIDs.
Sources:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Omudhome Ogbru, Pharm.D., Jay W. Marks, M.D., MedicineNet. 9/18/2005.
Questions and Answers: FDA Regulatory Actions for the COX-2 Selective and Non-Selective Non-Steroidal Anti-inflammatory drugs (NSAIDs). FDA/Center for Drug Evaluation and Research. April 7, 2005.

